AKBA icon

Akebia Therapeutics
AKBA

Overview Fund Activity

114 hedge funds and large institutions have $104M invested in Akebia Therapeutics in 2024 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+27
Holders Change %
+31.03%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
40
Increased
26
Reduced
25
Closed
13
Calls
$2.88M
Puts
$1.97M
Net Calls
+$905K
Net Calls Change
+$70K

Top Buyers

1
Qube Research & Technologies (QRT)
1
Qube Research & Technologies (QRT)
United Kingdom
$4.14M
2
Goldman Sachs
2
Goldman Sachs
New York
$2.59M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$1.87M
4
Assenagon Asset Management
4
Assenagon Asset Management
Luxembourg
$1.45M
5
Millennium Management
5
Millennium Management
New York
$5.98M

Top Sellers

1
AIM
1
Alerce Investment Management
Illinois
$24.2M
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$9.72M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$6.68M
4
BlackRock
4
BlackRock
New York
$4.65M
5
Morgan Stanley
5
Morgan Stanley
New York
$1.44M
Name Holding Trade Value Shares
Change 		Shares
Change %
FWM
126
Focused Wealth Management
New York
– -$81 -65 Closed
2 3 4 5
6